Home › Funds › Propel Bio Management, LLC › IRD

Propel Bio Management, LLC position in IRD

OPUS GENETICS INC · Health Care

Propel Bio Management, LLC reported holding 270,036 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.69% of its reported portfolio and ranking #27 among its reported holdings. Propel Bio Management, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)270.04K sh
Reported value held$1.31M
Portfolio Weight0.69%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's IRD position evolved

Propel Bio Management, LLC first disclosed a stake in IRD in Q3 2026 at 270,036 shares (US$1.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 270.04K $1.31M New

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 74 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Propel Bio Management, LLC held IRD?

Propel Bio Management, LLC has disclosed IRD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Propel Bio Management, LLC's current position in IRD?

As of Q3 2026, Propel Bio Management, LLC holds 270.04K shares of IRD (OPUS GENETICS INC), valued at $1.31M, representing 0.69% of its reported portfolio and ranking #27.

Has Propel Bio Management, LLC been buying or selling IRD?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC newly opened its position in IRD.

Which other funds hold IRD?

Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.